Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Gene Technology CorpfiledCriticalAdvanced Gene Technology Corp
Priority to TW093137635ApriorityCriticalpatent/TW200619224A/en
Publication of TW200619224ApublicationCriticalpatent/TW200619224A/en
Application grantedgrantedCritical
Publication of TWI376384BpublicationCriticalpatent/TWI376384B/zh
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The use of flavone derivatives of formula (I), in which R1, R2, R3, R4 and R5 independently represent hydrogen, hydroxy or an ester group; R6 represents hydrogen, hydroxy, an ester group or an O-glycoside group such as O-rhamnose, O-glucoside, O-retinoside or O-xyloside; and - - - represents a single bond or a double bond; or the pharmaceutically acceptable salts thereof as TNF α antagonists or inhibitors.
TW093137635A2004-12-062004-12-06Flavone derivatives as TNF- α inhibitors or antagonists
TW200619224A
(en)